儿童单侧感音神经性听力损失影像学检查临床获益评估:系统综述与Meta分析
该系统综述与Meta分析检索1978至2017年文献,纳入18项研究共1504例不明原因单侧感音神经性听力损失(USNHL)患儿,评估CT与MRI的诊断阳性率及临床相关性。结果显示CT对病理生理相关发现的合并诊断阳性率为37%(95%CI 25%-48%),MRI为35%(95%CI 22%-49%);但所有发现均无治疗后果,仅大前庭导水管(EVA)患儿可获预后与遗传信息。作者认为目前无充分证据支持对USNHL患儿强烈推荐影像学检查,利弊需在共享决策中权衡。
要点
- CT对不明原因USNHL患儿病理生理相关发现的合并诊断阳性率为37%(95%CI 25%-48%)。
- MRI对不明原因USNHL患儿病理生理相关发现的合并诊断阳性率为35%(95%CI 22%-49%)。
- 所有影像学发现均无治疗后果,仅EVA患儿可获预后与遗传信息。
核心结论
- 影像学在不明原因孤立性USNHL患儿中提供病因线索的合并频率约为35%至37%。
- 所有影像学发现均无治疗后果,仅EVA患儿可获预后与遗传信息。
- 目前无充分证据支持对USNHL患儿强烈推荐影像学检查,利弊需在共享决策中权衡。
研究设计与样本
- 系统综述与Meta分析,检索Cochrane Library、Embase、PubMed和Web of Science数据库1978至2017年发表的文献。
- 纳入标准为20例及以上USNHL患儿、年龄小于18岁、接受颞骨CT和/或MRI检查、以英文发表的研究。
- 共纳入18项研究,合计1504例参与者;其中15项为连续病例研究,3项为回顾性队列研究。
- 由两名作者独立提取人群特征、影像模态和异常患病率信息,并评估研究偏倚风险。
主要发现
- CT对不明原因USNHL患儿病理生理相关发现的合并诊断阳性率为37%(95%CI 25%-48%),MRI为35%(95%CI 22%-49%)。
- 耳蜗前庭异常的合并频率CT为19%(95%CI 14%-25%),MRI为16%(95%CI 7%-25%)。
- 耳蜗神经缺陷的合并频率MRI为16%(95%CI 3%-29%),相关耳蜗孔狭窄CT为44%(95%CI 36%-53%)。
- 大前庭导水管(EVA)在USNHL患儿中的合并检出频率CT为7%,MRI为12%。
临床怎么用
- 作者认为目前无充分证据支持对USNHL患儿强烈推荐影像学检查。
- 作者建议在共享决策中仔细权衡影像学检查的利弊。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Imaging used to determine the cause of unilateral sensorineural hearing loss (USNHL) in children is often justified by the high likelihood of detecting abnormalities, which implies that these abnormalities are associated with hearing loss and that imaging has a positive contribution to patient outcome or well-being by providing information on the prognosis, hereditary factors, or cause of hearing loss. OBJECTIVES: To evaluate the diagnostic yield of computed tomography (CT) and magnetic resonance imaging (MRI) in children with isolated unexplained USNHL and investigate the clinical relevance of these findings. EVIDENCE REVIEW: Cochrane Library, Embase, PubMed, and Web of Science databases were searched for articles published from 1978 to 2017 on studies of children with USNHL who underwent CT and/or MRI of the temporal bone. Two authors (F.G.R. and E.N.B.P.) independently extracted information on population characteristics, imaging modality, and the prevalence of abnormalities and assessed the studies for risk of bias. Eligibility criteria included studies with 20 or more patients with USNHL who had CT and/or MRI scans, a population younger than 18 years, and those published in English. MAIN OUTCOMES AND MEASURES: The pooled prevalence with 95% CI of inner ear abnormalities grouped according to finding and imaging modality. FINDINGS: Of 1562 studies, 18 were included with a total of 1504 participants included in the analysis. Fifteen studies were consecutive case studies and 3 were retrospective cohort studies. The pooled diagnostic yield for pathophysiologic relevant findings in patients with unexplained USNHL was 37% for CT (95% CI, 25%-48%) and 35% for MRI (95% CI, 22%-49%). Cochleovestibular abnormalities were found with a pooled frequency of 19% for CT (95% CI, 14%-25%) and 16% for MRI (95% CI, 7%-25%). Cochlear nerve deficiency and associated cochlear aperture stenosis had a pooled frequency of 16% for MRI (95% CI, 3%-29%) and 44% for CT (95% CI, 36%-53%), respectively. Enlarged vestibular aqueduct (EVA) was detected with a pooled frequency of 7% for CT and 12% for MRI in children with USNHL. CONCLUSIONS AND RELEVANCE: Imaging provided insight into the cause of hearing loss in a pooled frequency of about 35% to 37% in children with isolated unexplained USNHL. However, none of these findings had therapeutic consequences, and imaging provided information on prognosis and hereditary factors only in a small proportion of children, namely those with EVA. Thus, there is currently no convincing evidence supporting a strong recommendation for imaging in children who present with USNHL. The advantages of imaging should be carefully balanced against the drawbacks during shared decision making.
引用
- Ropers FG, Pham ENB, Kant SG, et al. Assessment of the Clinical Benefit of Imaging in Children With Unilateral Sensorineural Hearing Loss: A Systematic Review and Meta-analysis. JAMA Otolaryngol Head Neck Surg. 2019. PMID: 30946449. doi:10.1001/jamaoto.2019.0121
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。